Search for: "Novartis Pharmaceuticals Inc" Results 101 - 120 of 393
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Sep 2010, 12:39 pm by FDABlog HPM
Karst –    On September 22, 2010, Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
16 Apr 2009, 7:27 am
" Notably, "Eli Lilly and Co., Pfizer Inc., Novartis Pharmaceuticals Corp., Merck & Co. and Forest Pharmaceuticals Inc. were the biggest spenders. [read post]
19 Jun 2012, 11:30 am by Sean Wajert
Novartis Pharmaceuticals Corp., No. 11-5053 (6th Cir., 6/5/12). [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
3 May 2018, 11:19 am by m zamora
Canadian doctors were advised to closely monitor their Tasigna patients for signs of the life-threatening artery disease.Here is the link for the Canada label changes made in 2013:Subject: Updated information regarding the possible risk of developing atherosclerosis-related conditions with the use of TASIGNA* (nilotinib)Novartis Pharmaceuticals Canada, Inc. [read post]
23 Jun 2022, 12:57 pm by Linda C. Severin
In 2020, another pharmaceutical company, Novartis, paid $678 million for similar misconduct. [read post]
25 Nov 2011, 5:00 am by Bexis
Novartis Pharmaceuticals Corp., 2011 WL 5835414, slip op. [read post]
11 Jun 2019, 7:43 am by Dennis Crouch
[Watch Here] Today’s witnesses are primarily business leaders and in-house attorneys for large IP-focused businesses: Panel I Manny Schecter, Chief Patent Counsel at IBM Laurie Self, Senior Vice-President and Counsel at Qualcomm Byron Holz, Senior Counsel at Nokia Kim Chotkowski, VP at InterDigital Sean Reilly, Associate General Counsel at The Clearing House Payments Company Panel II Laurie Hill, VP for IP at Genentech Sean George, CEO at Invitae Gonzalo… [read post]
27 Jan 2022, 5:56 am by MaxVal
This week’s newest patent applications are from Integrated Solution for Systems Inc, Novartis, Abbott, Roche, Medtronic, Merck, Boston Scientific, Mastercard, IBM, Apple, Microsoft, and Intel. [read post]
22 Mar 2020, 5:42 am by Magdaleen Jooste
Sun Pharmaceutical Industries, issuing a temporary injunction, stopping Sun Pharmaceuticals from launching its generic version of Novartis’ Nilotinib. [read post]
14 Jun 2012, 11:55 am by Stephen Jenei
Related posts: Google Inc. to Acquire Patent Baristas for $1.3 Billion Could the FDA Put the Squeeze on Off-Label Revenues? [read post]
16 May 2022, 12:16 pm by Dennis Crouch
Level of Possession for WD negative claim limitations: Novartis Pharmaceuticals v. [read post]